• About
  • Services
  • Clients
  • Client News
  • PCG Research
  • PCG Digital
  • Contact
  • follow:

  • 13 May

    Quoin Pharmaceuticals Provides Corporate Update and Announces First Quarter 2025 Financial Results

    Continued Progress in Ongoing Late-Stage Netherton Syndrome Studies Announced Positive Clinical Data for Adult and Pediatric Netherton Patients Provided Clear Visual Evidence of QRX003 Mechanism of Action Patent Portfolio Expanded to Support Pipeline Growth Launch of NETHERTON NOW Advocacy Initiative ASHBURN, Va., May 13, 2025 (GLOBE NEWSWIRE) -- Quoin Pharmaceuticals… Read More..

    Share this:
  • 13 May

    Oncocyte Reports Q1 2025 Results and Business Progress

    Q1 2025 pharma services revenue of $2.1 million, at 62% gross margin Three of the top 10 U.S. transplant centers expected to participate in clinical trial Ten globally leading transplant hospitals are now using our GraftAssure research-use-only kits To reflect our larger market opportunity, we plan to rename the company… Read More..

    Share this:
  • 5 May

    DRYWORLD and G3 Management Announce Strategic Global Partnership to Drive Growth in Sports Apparel Market

    SANTA BARBARA, Calif., May 05, 2025 (GLOBE NEWSWIRE) -- DRYWORLD Brands Inc. (OTC: IBGR) (the ‘Company’), a leading sportswear and performance brand, announced today a strategic global partnership with G3 Management, a leader in strategic consulting and commercial brand development. The two companies have initiated the partnership through a Memorandum… Read More..

    Share this:
« Previous 1 … 22 23 24 25 26 … 257 Next »
  • Twitter feed is not available at the moment.
  • QUICK LINKS

    • About
    • Services
    • Clients
    • Client Media
    • PCG Media
    • PCG Research
    • Contact
    • Privacy Policy
    • Disclosures

    FOLLOW US

    Copyright © 2022 PCG Advisory.

    MENU logo
    • About
    • Services
    • Clients
    • Client News
    • PCG Research
    • PCG Digital
    • Contact